ABT vs IRMD
Abbott Laboratories · IRadimed Corporation
Relative return (rebased to 100)
Key stats
| Metric | ABT | IRMD |
|---|---|---|
| Price | $112.68 | $87.55 |
| Market Cap | $196.27B | $1.12B |
| P/E | 30.08 | 49.78 |
| P/B | 3.77 | 11.36 |
| P/S | 4.43 | 13.35 |
| ROE | 12.5% | 22.8% |
| Net Margin | 14.7% | 26.8% |
| Gross Margin | — | 76.7% |
| Revenue Growth | 5.7% | 14.4% |
| Dividend Yield | 2.13% | — |
| EPS | $3.75 | $1.76 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.